当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析 - 现金流量表

贝达药业

(300558)

  

流通市值:200.72亿  总市值:201.36亿
流通股本:4.19亿   总股本:4.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,647,137,175.411,731,866,820.84904,214,287.023,162,820,863.13
  收到的税费返还-606,964.671,119.7710,000
  收到其他与经营活动有关的现金90,716,752.8486,505,923.7864,545,475.4756,961,727.87
  经营活动现金流入小计2,737,853,928.251,818,979,709.29968,760,882.263,219,792,591
  购买商品、接受劳务支付的现金402,612,013.17237,570,385.1381,951,546.95414,772,859.69
  支付给职工以及为职工支付的现金476,111,063.84329,068,745.66208,785,163.25602,676,778.61
  支付的各项税费195,901,768.51147,204,205.6161,887,566.01116,659,370.99
  支付其他与经营活动有关的现金994,798,835.81660,158,084.68318,600,918.041,174,511,405.49
  经营活动现金流出小计2,069,423,681.331,374,001,421.08671,225,194.252,308,620,414.78
  经营活动产生的现金流量净额668,430,246.92444,978,288.21297,535,688.01911,172,176.22
二、投资活动产生的现金流量:
  收回投资收到的现金---31,581,183.16
  取得投资收益收到的现金999,000---
  处置固定资产、无形资产和其他长期资产收回的现金净额14,509.4214,509.42100,000141,527
  投资活动现金流入小计1,013,509.4214,509.42100,00031,722,710.16
  购建固定资产、无形资产和其他长期资产支付的现金481,735,187.19391,306,234.66192,857,786.75827,594,838.86
  投资支付的现金249,750,000--205,820,833.79
  投资活动现金流出小计731,485,187.19391,306,234.66192,857,786.751,033,415,672.65
  投资活动产生的现金流量净额-730,471,677.77-391,291,725.24-192,757,786.75-1,001,692,962.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金92,166,27892,166,278--
  取得借款收到的现金680,000,000580,000,000150,000,000533,600,000
  收到其他与筹资活动有关的现金37,780,000--111,150,000
  筹资活动现金流入小计809,946,278672,166,278150,000,000644,750,000
  偿还债务支付的现金632,810,000532,810,000150,010,000659,120,000
  分配股利、利润或偿付利息支付的现金134,753,554.17118,423,284.5619,326,846.43150,872,677.7
  支付其他与筹资活动有关的现金39,596,154.4318,916,728.678,854,00026,141,106.2
  筹资活动现金流出小计807,159,708.6670,150,013.23178,190,846.43836,133,783.9
  筹资活动产生的现金流量净额2,786,569.42,016,264.77-28,190,846.43-191,383,783.9
四、汇率变动对现金及现金等价物的影响1,901,864.44-196,210.48-133,207.851,590,510.79
五、现金及现金等价物净增加额-57,352,997.0155,506,617.2676,453,846.98-280,314,059.38
  加:期初现金及现金等价物余额471,682,855.12471,682,855.12471,682,855.12751,996,914.5
  期末现金及现金等价物余额414,329,858.11527,189,472.38548,136,702.1471,682,855.12
补充资料:
  净利润-130,707,401.1-386,979,402.58
  资产减值准备--2,647,368.81-21,156,712.37
  固定资产和投资性房地产折旧-93,425,612.98-115,204,009.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-93,425,612.98-115,204,009.77
  无形资产摊销-176,142,112.02-252,937,958.86
  处置固定资产、无形资产和其他长期资产的损失--72,940.02-588,954.91
  固定资产报废损失-3,848.86-591,577.32
  公允价值变动损失-76,016,377.9-26,305,321.32
  财务费用-40,840,938.22-44,044,061.2
  投资损失-6,504,780.23-14,663,608.75
  递延所得税--8,304,545.62-3,169,078.15
  其中:递延所得税资产减少--3,627,974.82-28,986,293.78
    递延所得税负债增加--4,676,570.8--25,817,215.63
  存货的减少--35,869,860.82-37,416,647.1
  经营性应收项目的减少--83,045,735.68-156,534,353.23
  经营性应付项目的增加-29,486,790.15--95,111,432.99
  其他-20,254,484.88--57,132,509.58
  现金的期末余额-527,189,472.38-471,682,855.12
  减:现金的期初余额-471,682,855.12-751,996,914.5
  现金及现金等价物的净增加额-55,506,617.26--280,314,059.38
公告日期2025-10-282025-08-202025-04-252025-04-18
审计意见(境内)标准无保留意见
TOP↑